Christopher R. Reidy

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
8 years
Director since
2022

8 years of board service in total across 2 boards, counting each seat separately. Longest: Embecta Corp., 4 years.

Embecta Corp. Director
4 years · Since 2022
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 19, 2026 Encompass Health Corporation Grant or award +284 $126.89 $36,037
Oct 15, 2026 Encompass Health Corporation Grant or award +20 — —
Jul 16, 2026 Encompass Health Corporation Grant or award +319 $112.40 $35,856
Jul 15, 2026 Encompass Health Corporation Grant or award +21 — —
May 7, 2026 Encompass Health Corporation Grant or award +1,634 — —
Apr 16, 2026 Encompass Health Corporation Grant or award +334 $106.48 $35,564
Apr 15, 2026 Encompass Health Corporation Grant or award +19 — —
Feb 11, 2026 Embecta Corp. Grant or award +22,841 — —
Jan 15, 2026 Encompass Health Corporation Grant or award +19 — —
Jan 15, 2026 Encompass Health Corporation Grant or award +346 $103.07 $35,662
Oct 15, 2025 Encompass Health Corporation Grant or award +16 — —
Oct 15, 2025 Encompass Health Corporation Grant or award +288 $123.23 $35,490
Jul 16, 2025 Encompass Health Corporation Grant or award +333 $106.89 $35,594
Jul 15, 2025 Encompass Health Corporation Grant or award +17 — —
May 1, 2025 Encompass Health Corporation Grant or award +1,424 — —

Questions about Christopher R. Reidy

What boards is Christopher R. Reidy on?

Christopher R. Reidy sits on the boards of Embecta Corp. and Encompass Health Corporation.

How long has Christopher R. Reidy served on boards?

Our records show at least 8 years of board service across 2 boards, the earliest from 2022.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.